Zoledronic Acid (Zometa Reclast ) Medicare Advantage Policy Guideline Author: UnitedHealthcare Subject: This policy addresses the use of zoledronic acid (Zometa Reclast ). Applicable Procedure Code: J3489. Created Date: 6:
[IV]) and Monoclonal Antibodies in the The following ICD-10-CM codes support medical necessity and provide coverage for HCPCS code: J3489 (Reclast).
Reclast, Zometa Zoledronic acid, 1 mg. J3490 Auth. Required. Unclassified S5497 No Auth if billed with a J code. Home infusion therapy, catheter care
J3247: Permanent J-code for the IV formulation of COSENTYX Effective J, for all sites of care. If COSENTYX is administered on or after J, the permanent J-code replaces the miscellaneous J-code J3590.
You would be correct that the therapeutic infusions , CPT codes would be correct for generic Reclast. Documentation should have the
Reclast is contraindicated for patients with chronic renal failure. Kim J. Robertson. Febru. Regulatory Project Manager. Date.
J . CPT CODE: J. $7.62. J Q. CPT CODE: J. $5.03. J . CPT CODE: J. $5.03 CODE: $2,300.78. S . CPT CODE: $697.04. S .
J3247: Permanent J-code for the IV formulation of COSENTYX Effective J, for all sites of care If COSENTYX is administered on or after J, the permanent J-code replaces the miscellaneous J-code J3590.
Under the Healthcare Common Procedure Coding System (HCPCS), the BRIUMVI J-Code (J2329) will become effective J. J-Code for BRIUMVI
R.